# Tygacil Drug Use Investigation

> **NCT01789905** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 116 (actual)

## Conditions studied

- Intra-Abdominal Infections
- Skin Disease, Infectious

## Interventions

- **DRUG:** Tigecycline (Tygacil)

## Key facts

- **NCT ID:** NCT01789905
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04-15
- **Primary completion:** 2017-06-16
- **Final completion:** 2017-06-16
- **Target enrollment:** 116 (ACTUAL)
- **Last updated:** 2019-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01789905

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01789905, "Tygacil Drug Use Investigation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01789905. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*